摘要
肺癌是中国发病率、死亡率均位居第1位的恶性肿瘤。多学科团队(MDT)诊疗通过对疾病多维度的讨论和分析给肿瘤患者带来很多益处,如可增加患者满意度,减少住院费用,缩短治疗等待时间,提供更合理的诊疗路径和策略,减少医疗纠纷,增加高质量临床试验的患者入组机会,改善患者预后和生活质量等。目前,中国肺癌MDT在指南遵循度、民主决策、落地执行和反馈、会议记录、患者随访等方面还有很大的提升空间。共识结合中国肺癌MDT诊疗经验和前沿的国际肿瘤MDT诊疗经验,构建以患者为中心的肺癌MDT诊疗模式,包括MDT责任义务、组织架构、工作形式、标准流程、评估方法与激励机制等体系。共识由中国胸部肿瘤研究协作组、中国抗癌协会肺癌专业委员会、中华医学会肿瘤学分会肺癌学组和中国医师协会肿瘤多学科诊疗专业委员会联合制定,旨在为中国肺癌MDT提供流程和标准。
Lung cancer is by far the most common cancer and the leading cause of cancer death in China.Through multidimensional discussion and analysis of disease,the multidisciplinary team(MDT)diagnosis and treatment brings lots of benefits for cancer patients,including increasing patient satisfaction,reducing hospitalization expense,shortening treatment waiting time,providing more reasonable diagnosis and treatment pathways and strategies,relieving medical disputes,increasing enrollment opportunities for patients in high-quality clinical trials,patients′prognosis and life quality and so on.Presently,lung cancer MDT in China needs to be improved,including guideline following,democratic decision,landing performance and feedback,meeting records,patient follow-up and so on.So this consensus combines lung cancer MDT experience of China with leading-edge global oncology MDT experience to construct patient-centered lung cancer MDT diagnosis and treatment model,including MDT responsibility and obligations,organizational framework,working modality,standard procedures,assessment methods,and encouragement mechanisms and so on.Chinese Thoracic Oncology Group;Chinese Society of Lung Cancer;Lung Cancer Group of Oncology Branch,Chinese Medical Association;Multidisciplinary Team Diagnosis and Treatment Committee,Chinses Medical Doctor Association jointly publish this consensus.The purpose of this consensus is to provide procedures and criteria for lung cancer MDT of China.
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
2020年第10期817-828,共12页
Chinese Journal of Oncology
关键词
肺肿瘤
多学科团队
诊断
治疗
专家共识
Lung neoplasms
Multidisciplinary team
Diagnosis
Treatment
Expert consensus
